Biohaven Pharmaceutical Holding Co. Ltd.
(NYSE : BHVN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 0.13%34.560.9%$1199.54m
JNJJohnson & Johnson 1.66%143.310.7%$1131.20m
BMYBristol-Myers Squibb Co. 1.90%60.271.0%$995.69m
MRKMerck & Co., Inc. 1.07%79.620.7%$858.23m
ABBVAbbVie, Inc. 0.34%99.221.9%$813.91m
LLYEli Lilly & Co. 1.62%166.521.1%$710.39m
AZNAstraZeneca Plc 0.56%54.101.2%$302.78m
RPRXRoyalty Pharma Plc 0.08%45.770.1%$252.90m
VXRTVaxart, Inc. -16.62%6.150.0%$187.37m
NVSNovartis AG 1.09%88.520.2%$162.13m
GSKGlaxoSmithKline Plc -0.46%41.030.2%$121.97m
RGENRepligen Corp. -0.81%125.637.2%$119.18m
NVONovo Nordisk A/S -0.63%65.940.1%$94.23m
RETAReata Pharmaceuticals, Inc. 1.67%160.493.4%$89.18m
SNYSanofi 1.02%52.150.2%$80.94m

Company Profile

Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.